Egetis Therapeutics AB (publ) (STO: EGTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
5.80
-0.09 (-1.53%)
Aug 30, 2024, 5:29 PM CET

Egetis Therapeutics AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Net Income
-69.4-200.6207.3209.771.8102.7
Upgrade
Depreciation & Amortization
1.10.90.41.20.70.5
Upgrade
Other Operating Activities
186.2300.5-153.9-131.8-53-67.5
Upgrade
Change in Accounts Receivable
-1.2-14.7-2.1-18.483.8-45.9
Upgrade
Change in Other Net Operating Assets
-42.616.32.6-4.6-6.452.1
Upgrade
Operating Cash Flow
74.1102.454.356.196.941.9
Upgrade
Operating Cash Flow Growth
1.93%88.58%-3.21%-42.11%131.26%-
Upgrade
Capital Expenditures
-4.9-4.7-1.5-0.5-0.7-
Upgrade
Sale of Property, Plant & Equipment
245245-4.9--
Upgrade
Sale (Purchase) of Intangibles
-----0.1-1.6
Upgrade
Other Investing Activities
---0.1--
Upgrade
Investing Cash Flow
-520.4-383.4-134.1-458.9-830.1-1,402
Upgrade
Long-Term Debt Issued
-345.2132.92341,814895.4
Upgrade
Long-Term Debt Repaid
--183.6-7.9-87.9-1,709-2.3
Upgrade
Net Debt Issued (Repaid)
148.8161.6125146.1105.5893.1
Upgrade
Issuance of Common Stock
----2,000-
Upgrade
Financing Cash Flow
438.6161.6125146.12,106893.1
Upgrade
Foreign Exchange Rate Adjustments
20.92.5-1.1-2.11.8
Upgrade
Miscellaneous Cash Flow Adjustments
-----963469.3
Upgrade
Net Cash Flow
-5.7-118.547.7-257.8407.64.6
Upgrade
Free Cash Flow
69.297.752.855.696.241.9
Upgrade
Free Cash Flow Growth
-4.55%85.04%-5.04%-42.20%129.59%-
Upgrade
Free Cash Flow Margin
22.65%33.45%20.11%24.50%53.92%38.20%
Upgrade
Free Cash Flow Per Share
1.061.660.900.941.63-
Upgrade
Cash Income Tax Paid
----1.3-3.7
Upgrade
Levered Free Cash Flow
-21.0633.9658.1325.7480.69-
Upgrade
Unlevered Free Cash Flow
62.75114.7897.1953.3108.13-
Upgrade
Change in Net Working Capital
46.2-13.2-8.628.9-66.6-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.